Smoking-related interstitial lung diseases |
| |
Authors: | Vassallo Robert Ryu Jay H |
| |
Affiliation: | Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA. ryu.jay@mayo.edu |
| |
Abstract: | Cigarette smoke, a toxic collection of thousands of chemicals generated from combustion of tobacco, is recognized as the primary causative agent of certain diffuse interstitial and bronchiolar lung diseases. Most patients afflicted with these disorders are cigarette smokers, and smoking cessation has been shown to be capable of inducing disease remission and should occupy a pivotal role in the management of all smokers with these diffuse lung diseases. The role of pharmacotherapy with corticosteroids or other immunomodulating agents is not well established but may be considered in patients with progressive forms of smoking-related interstitial lung diseases. |
| |
Keywords: | Smoking Interstitial lung disease Respiratory bronchiolitis Desquamative interstitial pneumonia Fibrosis Pulmonary Langerhans cell histiocytosis Acute eosinophilic pneumonia |
本文献已被 ScienceDirect PubMed 等数据库收录! |